Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/1998
08/06/1998WO1998033924A1 O-fucosyltransferase
08/06/1998WO1998033922A1 The neurotrophic factor nnt-1
08/06/1998WO1998033921A1 Novel human cystatin-like protein
08/06/1998WO1998033920A2 Tissue factor pathway inhibitor-3
08/06/1998WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998WO1998033915A1 Breast cancer specific gene 1
08/06/1998WO1998033907A1 A tumor suppressor designated ts10q23.3
08/06/1998WO1998033892A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033818A1 Human anion channel
08/06/1998WO1998033816A1 Nucleic acid encoding an acetyl-coenzyme-a transporter protein
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998027116A3 Protein binding fragments of gravin
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998CA2280229A1 Breast cancer specific gene 1
08/06/1998CA2279991A1 Human anion channel
08/06/1998CA2279551A1 Reagents and methods useful for detecting diseases of the lung
08/06/1998CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998CA2279345A1 Tissue factor pathway inhibitor-3
08/06/1998CA2279265A1 Novel human cystatin-like protein
08/06/1998CA2278849A1 A tumor suppressor designated ts10q23.3
08/06/1998CA2278848A1 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998CA2278771A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998CA2277266A1 O-fucosyltransferase
08/05/1998EP0856583A2 Protein rab3 GEP
08/05/1998EP0856581A2 Stably transfected cell lines expressing GABA-A receptors
08/05/1998EP0856520A1 Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
08/05/1998EP0856314A1 Immunosuppressant
08/05/1998EP0856057A2 Polynucleotide and encoded protein useful in controlling of melolontha sp. scarabs
08/05/1998EP0856056A1 Fibronectic binding protein b compounds
08/05/1998EP0856054A1 Monoclonal antibody br110 and uses thereof
08/05/1998EP0856050A1 Transforming growth factor alpha hi
08/05/1998EP0856009A1 Cd6 ligand
08/05/1998EP0856006A1 Cytostatin ii
08/05/1998EP0856005A1 The aiolos gene
08/05/1998EP0855918A1 Chicken interleukin-15 and uses thereof
08/05/1998EP0765478B1 Positive and positive/negative cell selection mediated by peptide release
08/05/1998EP0722452A4 Nf-at polypeptides and polynucleotides
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998EP0644930B1 Monoclonal antibody against the extra-villous trophoblast
08/05/1998CN1189851A Human Beta 2 integrin alpha subunit
08/05/1998CN1189840A Hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits
08/05/1998CN1189836A DNA sequence and encoded mammary-specific breast cancer protein
08/05/1998CN1189539A Soluble expression carrier and its fusion protein of novel thioredoxin
08/05/1998CN1189538A Vaccines
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5790421 Computer apparatus for expressing a three dimensional structure of a G-CSF molecule or analogs thereof
08/04/1998US5789565 Serine threonine kinase receptor, ALK-7
08/04/1998US5789554 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
08/04/1998US5789551 Human leukocyte interferon Hu-IFN-α001
08/04/1998US5789550 TRAF inhibitors
08/04/1998US5789547 Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
08/04/1998US5789544 Gene expression for vaccines
08/04/1998US5789543 Vertebrate embryonic pattern-inducing proteins and uses related thereto
08/04/1998US5789377 Blocking tumor necrosis factor
08/04/1998US5789245 Genetic engineering
08/04/1998US5789237 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
08/04/1998US5789234 Expression systems for amidating enzyme
08/04/1998US5789233 Amino acid sequence that selectively binds with antibody; for preparation of a vector vaccine against coccidiosis.
08/04/1998US5789208 Polyclonal antibody libraries
08/04/1998US5789203 Protein complexes having factor VIII:C activity and production thereof
08/04/1998US5789202 DNA encoding a novel penicillin binding protein from streptococcus pneumoniae
08/04/1998US5789200 Polypeptides and dna(rna) codes by genetic engineering for diagnosis and treatment of cancer, prostate, breast, lung or epithelial tumors
08/04/1998US5789199 Process for bacterial production of polypeptides
08/04/1998US5789196 Recombinantly produced β4 neuronal nicotinic acetylcholine receptor subunits
08/04/1998US5789194 Parasitic helminth venom allergen antigen 5-like genes and proteins
08/04/1998US5789193 Increased production of secreted proteins by recombinant eukaryotic cells
08/04/1998US5789192 Mammalian receptors for interleukin-10 (IL-10)
08/04/1998US5789177 Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 1
08/04/1998US5789153 Method of quantitating nucleic acid
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
08/04/1998CA2150263C Purification, composition and specificity of heparinase i, ii and iii from flavobacterium heparinum
08/04/1998CA2098296C Pseudomonas peptide composition and method for producing the same
08/04/1998CA2047090C Genetic mechanisms of tumor suppression
08/04/1998CA1339980C Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/30/1998WO1998032867A1 Synthetic leader peptide sequences
07/30/1998WO1998032866A1 Fusion proteins for intracellular and intercellular transport and their uses
07/30/1998WO1998032865A1 Novel prostate-associated kallikrein
07/30/1998WO1998032863A2 Mammalian thioredoxin
07/30/1998WO1998032856A1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l)
07/30/1998WO1998032854A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998WO1998032851A1 Two human homologues of galectin-5
07/30/1998WO1998032431A1 Antigen inducers, vaccine precursors, vaccines, antibodies, neutralizing antibodies, antitoxins, idiotypic antibodies, and anti-idiotypic antibodies induced by the idiotypic antibodies
07/30/1998WO1998025958A3 Mammalian cell surface antigens comprising structural motifs characteristic of a member of the TNF ligand family
07/30/1998WO1998023775A3 DNA for evaluating the progression potential of cervical lesions
07/30/1998WO1998023646A3 Binding agents specific for IGA receptor
07/30/1998WO1998022591A3 Carrot antifreeze polypeptides
07/30/1998WO1998022507A3 Receptor tyrosine kinase genes
07/30/1998WO1998020130A3 Secreted proteins and polynucleotides encoding them
07/30/1998WO1998017687A3 Secreted proteins and polynucleotides encoding them
07/30/1998WO1998010787A3 Pharmaceutical compositions for the treatment of immune disorders
07/30/1998CA2279260A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998CA2279241A1 Mammalian thioredoxin
07/30/1998CA2278623A1 Novel prostate-associated kallikrein
07/30/1998CA2278463A1 Two human homologues of galectin-5
07/30/1998CA2278002A1 Fusion proteins for intracellular and intercellular transport and their uses
07/29/1998EP0855444A2 Aspartic proteinase 2 (ASP2)